Previous Close | 3.7700 |
Open | 3.7900 |
Bid | 3.8000 x 27000 |
Ask | 3.8300 x 3100 |
Day's Range | 3.4750 - 4.1200 |
52 Week Range | 1.4700 - 16.3100 |
Volume | |
Avg. Volume | 6,437,008 |
Market Cap | 1.225B |
Beta (5Y Monthly) | 1.63 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.3870 |
Earnings Date | Nov 07, 2022 - Nov 11, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for AMRS
The industrial biotech company genetically engineers microbes to produce useful chemicals, such as cosmetic or food ingredients. It has yeast strains capable of producing cannabinoid ingredients, which are more commonly associated with cannabis plants. Another makes a cosmetic ingredient that's commonly harvested from blue sharks.
As you might know, Amyris, Inc. ( NASDAQ:AMRS ) last week released its latest quarterly, and things did not turn out so...
This call is being webcast live on the events page of the investor section of the Amyris' website at amyris.com. You may listen to a webcast replay of this call by going to the investor section of Amyris' website. With me on today's call are John Melo, president and chief executive officer; and also Eduardo Alvarez, chief operating officer to support our Q&A session today.